Advertisement
Advertisement
KPRX
Kiora Pharmaceuticals, Inc. Common Stock
2.58
USDSponsored
-0.06
-2.27%
Aug 10, 16:00 UTC -4
Closed
After-Market
2.57
-0.01
-0.39%
KPRX Earnings Reports
Positive Surprise Ratio
KPRX beat 25 of 40 last estimates.
63%
Next Report
Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.70
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/-7100.00%
Kiora Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On Aug 06, 2026, KPRX reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.63 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.70 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ZOETIS INC.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.87
Actual
$1.87
Surprise
-0.22%
Oruka Therapeutics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.52
Actual
-$0.55
Surprise
-4.62%
Definium Therapeutics, Inc. Common Shares
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.55
Actual
-$1.44
Surprise
-158.25%
Guardian Pharmacy Services, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.27
Actual
$0.28
Surprise
+3.76%
Cronos Group Inc. Common Share
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.03
Surprise
0.00%
Relmada Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.20
Actual
-$0.11
Surprise
+45.95%
Avita Medical, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.25
Surprise
+14.50%
SIGA Technologies Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-Actual
$0.17
Surprise
-
Tonix Pharmaceuticals Holding Corp.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$2.75
Actual
-$2.44
Surprise
+11.29%
Fractyl Health, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.85%
FAQ
What were Kiora Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Kiora Pharmaceuticals, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Kiora Pharmaceuticals, Inc. Common Stock's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Kiora Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 05, 2026.
What are the forecasts for Kiora Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 3
analysts, Kiora Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.70 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement